Nanophysics has innovative solutions that transcend traditional drug delivery mechanisms. At the nanoscale, materials exhibit unique properties, allowing for precise manipulation and control over drug formulations. Nanoparticles, with dimensions ranging from 1 to 100 nanometers, enable enhanced bioavailability, targeted drug delivery, and improved therapeutic efficacy. These advancements have significant implications for pharmaceutical applications, as nanophysics facilitates the design of drug carriers capable of navigating physiological barriers, such as the blood-brain barrier, enabling the treatment of previously inaccessible conditions.
Moreover, nanophysics enables the customization of drug release profiles, optimizing therapeutic outcomes while minimizing side effects. The interdisciplinary nature of nanophysics in pharmaceuticals underscores its potential to redefine drug development, opening avenues for personalized medicine and novel treatment modalities. As researchers continue to unravel the intricacies of nanoscale phenomena, the integration of nanophysics in pharmaceuticals holds promise for addressing unmet medical needs and fostering a new era of precision medicine.
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami School of Medicine, United States
Title : Tailored cellular environments to enable drug design
Lan Wang, Paretor LLC, United States
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N D Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, InMedStar and Biona, Russian Federation
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, University of Alberta, Canada
Title : Application of quality by design for pulmonary liposomes: Preliminary study to nano in-microparticle
Lucas Amaral Machado, University of Sao Paulo State – UNESP, Brazil
Title : Precision diagnostics: Effectiveness of innovative imaging technologies for early detection of lung cancers
Huiqin Yang, ICON Clinical Research Ltd, United Kingdom
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil